People · Operator
Named in public records as an officer, director or promoter · active 2017–2024 · Biotechnology, Other Technology, Mining & Resources
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Convergent Therapeutics, Inc. | — | Biotechnology | Series B | $51.4M | $153.1M | 2023 |
| BIOT Holdings, Inc. | — | Other Technology | Series B | $16.2M | $173.6M | 2023 |
| Gold Street Reserves, LLC | — | Mining & Resources | Pre-Seed | $100K | $667K | 2017 |
Alexander Brown at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Alexander Brown on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jake Simson | 1 | 6 |
| Brian Kibby | 1 | 4 |
| Eric Sullivan | 1 | 3 |
| Tal Zaks | 1 | 3 |
| BRIAN TURNER | 1 | 3 |
| BENJAMIN BIRNBAUM | 1 | 2 |
| Lorraine Akiba | 1 | 1 |
| Christopher Paulick | 1 | 1 |
| Jim Trenkle | 1 | 1 |
| Philip Kantoff | 1 | 1 |
| Neil Bander | 1 | 1 |
| Terry Turner | 1 | 1 |
| Bridget Davies | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.